Keyphrases
Antiphospholipid Syndrome
79%
Systemic Lupus Erythematosus
72%
Macrophages
50%
Placenta
50%
Pregnancy Outcome
45%
Adverse Pregnancy Outcomes
41%
Interferon-α (IFN-α)
34%
Disease Syndrome
31%
Hydroxychloroquine
27%
β2-glycoprotein I (β2GPI)
22%
Meta-analysis
22%
Systematic Meta-analysis
22%
Outcome Prediction
22%
Systemic Autoimmune Diseases
22%
Myxovirus Resistance Protein A
22%
Healthy Controls
22%
Rheumatic Diseases
22%
Immunohistochemical Analysis
22%
Preeclampsia
19%
Fetal Growth Restriction
19%
Preterm Birth
18%
Pregnancy Loss
14%
Decidua
11%
Villi
11%
Lupus Nephritis
10%
Chronic Hypertension
10%
Preconception Risk Factors
9%
Before Pregnancy
9%
During Pregnancy
9%
Live Birth
8%
Preterm Birth Risk
8%
CD123
7%
Risk Factors
7%
Small-for-gestational Age
7%
Autoimmune Disease
7%
Anti-Ro52
6%
SLE Disease Activity Index (SLEDAI)
5%
Risk of Bias Assessment
5%
Patient-tailored
5%
Week of Gestation
5%
Odds Ratio
5%
Risk Assessment
5%
Pregnant Women
5%
Chloroquine
5%
Mechanism of Action
5%
Antiphospholipid Antibodies
5%
Immunology and Microbiology
Antiphospholipid Syndrome
100%
Systemic Lupus Erythematosus
97%
Macrophage
50%
Placenta
50%
interferon
39%
Upregulation
27%
Hydroxychloroquine
24%
Immunoglobulin M
22%
Immunoglobulin G
22%
Granulocyte
22%
Glycoprotein
22%
Monospecific Antibody
22%
Neutrophil Extracellular Traps
22%
Isoetarine
22%
Autoantibodies
22%
Systemic Autoimmune Disease
22%
Fetus Growth
22%
Orthomyxoviridae
22%
Rheumatic Disease
22%
Decidua
16%
Phospholipid Antibody
11%
Autoimmune Disease
10%
CD20
9%
CD3 Antigen
9%
CD68
9%
Chloroquine
5%
Medicine and Dentistry
Antiphospholipid Syndrome
63%
Systemic Lupus Erythematosus
57%
Obstetrics
29%
Hydroxychloroquine
27%
Premature Labor
23%
Beta2 Glycoprotein 1
22%
Retrospective Cohort Study
22%
Systematic Review
22%
Meta-Analysis
22%
Systemic Autoimmune Disease
22%
Pre-Eclampsia
13%
Diseases
13%
Antiphospholipid Antibody
11%
Autoimmune Disease
10%
Glycoprotein
9%
Lupus Nephritis
9%
Conception
7%
Pregnancy
7%
Disease Activity
7%
Neonatal Infant
7%
Small for Gestational Age
6%
Targeted Therapy
6%
Thrombosis
5%
Chloroquine
5%
